Capital Square
BMY icon

Capital Square’s Bristol-Myers Squibb BMY Stock Holding History

Capital Square’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$511K Buy
8,184
+3,099
+61% +$196K 0.23% 108
2026
Q2 		$293K Buy
5,085
+35
+0.7% +$2.01K 0.13% 173
2026
Q1 		$297K Buy
5,050
+38
+0.8% +$2.22K 0.14% 158
2025
Q4 		$270K Sell
5,012
-991
-17% -$47.7K 0.14% 159
2025
Q3 		$271K Buy
6,003
+59
+1% +$2.76K 0.14% 154
2025
Q2 		$279K Buy
5,944
+50
+0.8% +$2.45K 0.15% 152
2025
Q1 		$359K Buy
5,894
+44
+0.8% +$2.56K 0.21% 111
2024
Q4 		$349K Buy
5,850
+8
+0.1% +$447 0.2% 121
2024
Q3 		$302K Buy
5,842
+49
+0.8% +$2.3K 0.18% 120
2024
Q2 		$247K Sell
5,793
-462
-7% -$20.7K 0.16% 128
2024
Q1 		$339K Buy
6,255
+79
+1% +$4.02K 0.24% 102
2023
Q4 		$317K Sell
6,176
-134
-2% -$7.03K 0.36% 74
2023
Q3 		$359K Buy
6,310
+92
+1% +$5.64K 0.48% 58
2023
Q2 		$398K Buy
6,218
+44
+0.7% +$2.95K 0.37% 78
2023
Q1 		$437K Buy
6,174
+274
+5% +$19.3K 0.4% 70
2022
Q4 		$425K Sell
5,900
-138
-2% -$10.4K 0.38% 76
2022
Q3 		$429K Buy
6,038
+212
+4% +$15.4K 0.39% 71
2022
Q2 		$448K Sell
5,826
-176
-3% -$13.4K 0.37% 75
2022
Q1 		$438K Sell
6,002
-138
-2% -$9.27K 0.31% 90
2021
Q4 		$381K Buy
6,140
+49
+0.8% +$2.87K 0.26% 99
2021
Q3 		$362K Buy
6,091
+735
+14% +$48.4K 0.26% 104
2021
Q2 		$359K Buy
5,356
+106
+2% +$6.91K 0.26% 103
2021
Q1 		$328K Buy
5,250
+1,167
+29% +$72.6K 0.24% 115
2020
Q4 		$253K Sell
4,083
-453
-10% -$27.9K 0.21% 123
2020
Q3 		$273K Sell
4,536
-46
-1% -$2.77K 0.28% 104
2020
Q2 		$269K Sell
4,582
-96
-2% -$5.74K 0.29% 107
2020
Q1 		$261K Buy
4,678
+79
+2% +$4.83K 0.3% 93
2019
Q4 		$295K Buy
+4,599
New +$263K 0.28% 96

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Capital Square's BMY Position: Q3 2026 in Review

Capital Square increased its Bristol-Myers Squibb (BMY) stake by 61% in Q3 2026, buying an estimated $196K and bringing the position to 8,184 shares worth $511K. The position accounts for 0.23% of the portfolio, ranked #108.

Capital Square first reported a position in BMY in Q4 2019 and has held it in 28 quarters since. 920 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Capital Square held 8,184 shares of Bristol-Myers Squibb worth $511K as of Q3 2026.
  • Capital Square bought 3,099 Bristol-Myers Squibb shares in Q3 2026, an estimated $196K.
  • Bristol-Myers Squibb made up 0.23% of Capital Square's portfolio in Q3 2026, its #108 holding.
  • Capital Square first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 28 quarters since.
  • 920 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Capital Square's 13F filing for Q3 2026, filed 19 Oct 2026.